CN106668722A - 回族中药莪术胃癌康片及其制备方法 - Google Patents
回族中药莪术胃癌康片及其制备方法 Download PDFInfo
- Publication number
- CN106668722A CN106668722A CN201510749396.4A CN201510749396A CN106668722A CN 106668722 A CN106668722 A CN 106668722A CN 201510749396 A CN201510749396 A CN 201510749396A CN 106668722 A CN106668722 A CN 106668722A
- Authority
- CN
- China
- Prior art keywords
- cancer
- gastric cancer
- herba
- tablet
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 206010017758 gastric cancer Diseases 0.000 title claims abstract description 36
- 208000005718 Stomach Neoplasms Diseases 0.000 title claims abstract description 35
- 201000011549 stomach cancer Diseases 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000411851 herbal medicine Species 0.000 claims abstract description 7
- 230000000694 effects Effects 0.000 claims description 32
- 239000000284 extract Substances 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 238000011085 pressure filtration Methods 0.000 claims description 9
- -1 pressure filtration Substances 0.000 claims description 9
- 239000008399 tap water Substances 0.000 claims description 9
- 235000020679 tap water Nutrition 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 7
- 240000000599 Lentinula edodes Species 0.000 claims description 6
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 235000013599 spices Nutrition 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 230000004087 circulation Effects 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 4
- 235000019640 taste Nutrition 0.000 claims description 4
- 229910000831 Steel Inorganic materials 0.000 claims description 3
- 229920001617 Vinyon Polymers 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000428 dust Substances 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000010959 steel Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 44
- 201000011510 cancer Diseases 0.000 abstract description 28
- 229940079593 drug Drugs 0.000 abstract description 12
- 230000000144 pharmacologic effect Effects 0.000 abstract description 7
- 206010009944 Colon cancer Diseases 0.000 abstract description 6
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract description 3
- 208000002699 Digestive System Neoplasms Diseases 0.000 abstract description 3
- 208000000461 Esophageal Neoplasms Diseases 0.000 abstract 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 201000004101 esophageal cancer Diseases 0.000 abstract 1
- 201000004637 gastric cardia carcinoma Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 239000000796 flavoring agent Substances 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 210000000214 mouth Anatomy 0.000 description 7
- 229920001491 Lentinan Polymers 0.000 description 6
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 6
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 229940115286 lentinan Drugs 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 6
- 235000012661 lycopene Nutrition 0.000 description 6
- 229960004999 lycopene Drugs 0.000 description 6
- 239000001751 lycopene Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 6
- 201000009030 Carcinoma Diseases 0.000 description 5
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 5
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 201000005619 esophageal carcinoma Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 102000000588 Interleukin-2 Human genes 0.000 description 4
- 108010002350 Interleukin-2 Proteins 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000006907 apoptotic process Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 239000002435 venom Substances 0.000 description 4
- 231100000611 venom Toxicity 0.000 description 4
- 210000001048 venom Anatomy 0.000 description 4
- 206010003694 Atrophy Diseases 0.000 description 3
- 206010008909 Chronic Hepatitis Diseases 0.000 description 3
- 241000227653 Lycopersicon Species 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000032023 Signs and Symptoms Diseases 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000037444 atrophy Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 206010005003 Bladder cancer Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 2
- 206010019375 Helicobacter infections Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062038 Lip neoplasm Diseases 0.000 description 2
- 206010025323 Lymphomas Diseases 0.000 description 2
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000024770 Thyroid neoplasm Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 208000024558 digestive system cancer Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 201000010231 gastrointestinal system cancer Diseases 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000006721 lip cancer Diseases 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 208000007442 rickets Diseases 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000003867 tiredness Effects 0.000 description 2
- 208000016255 tiredness Diseases 0.000 description 2
- 201000005112 urinary bladder cancer Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- MXYUKLILVYORSK-UHFFFAOYSA-N (+/-)-allo-lobeline Natural products C1CCC(CC(=O)C=2C=CC=CC=2)N(C)C1CC(O)C1=CC=CC=C1 MXYUKLILVYORSK-UHFFFAOYSA-N 0.000 description 1
- MXYUKLILVYORSK-HBMCJLEFSA-N (-)-lobeline Chemical compound C1([C@@H](O)C[C@H]2N([C@H](CCC2)CC(=O)C=2C=CC=CC=2)C)=CC=CC=C1 MXYUKLILVYORSK-HBMCJLEFSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000830 Acute leukaemia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 101000633503 Homo sapiens Nuclear receptor subfamily 2 group E member 1 Proteins 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- OWGJQNXIWMMDTH-COPRSSIGSA-N Lobelanidine Chemical compound C1([C@H](O)C[C@@H]2N([C@@H](CCC2)C[C@H](O)C=2C=CC=CC=2)C)=CC=CC=C1 OWGJQNXIWMMDTH-COPRSSIGSA-N 0.000 description 1
- OWGJQNXIWMMDTH-ZDNVTZCJSA-N Lobelanidine Natural products O[C@@H](C[C@@H]1N(C)[C@H](C[C@@H](O)c2ccccc2)CCC1)c1ccccc1 OWGJQNXIWMMDTH-ZDNVTZCJSA-N 0.000 description 1
- IDEMKXUAULKYJV-BGYRXZFFSA-N Lobelanine Chemical compound C([C@@H]1N([C@@H](CCC1)CC(=O)C=1C=CC=CC=1)C)C(=O)C1=CC=CC=C1 IDEMKXUAULKYJV-BGYRXZFFSA-N 0.000 description 1
- IDEMKXUAULKYJV-UHFFFAOYSA-N Lobelanine Natural products C1CCC(CC(=O)C=2C=CC=CC=2)N(C)C1CC(=O)C1=CC=CC=C1 IDEMKXUAULKYJV-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- PPQNQXQZIWHJRB-UHFFFAOYSA-N Methylcholanthrene Chemical compound C1=CC=C2C3=CC4=CC=C(C)C(CC5)=C4C5=C3C=CC2=C1 PPQNQXQZIWHJRB-UHFFFAOYSA-N 0.000 description 1
- 208000001907 Mushroom Poisoning Diseases 0.000 description 1
- 102100029534 Nuclear receptor subfamily 2 group E member 1 Human genes 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241001250596 Pleione Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000033781 Thyroid carcinoma Diseases 0.000 description 1
- 206010043966 Tongue neoplasm malignant stage unspecified Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 102000034337 acetylcholine receptors Human genes 0.000 description 1
- 150000000475 acetylene derivatives Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- RBFQJDQYXXHULB-UHFFFAOYSA-N arsane Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 206010016629 fibroma Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 208000010749 gastric carcinoma Diseases 0.000 description 1
- 201000011587 gastric lymphoma Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 229930013610 lobeline Natural products 0.000 description 1
- 229960002339 lobeline Drugs 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000001589 lymphoproliferative effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 201000011598 pylorus cancer Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 208000020615 rectal carcinoma Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 210000004336 spermatogonium Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 208000013077 thyroid gland carcinoma Diseases 0.000 description 1
- 208000013076 thyroid tumor Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明详述了回族中药“莪术胃癌康片”的配方及其制备方法,该药是一种治疗晚期胃癌特别是因为各种原因无法进行手术的晚期胃癌的绿色高科技中草药。它是以莪术、绞股蓝、肿节风、乌药、凤尾草、半边莲等中草药按一定比例混合加水煎熬、提取、浓缩、压片而成的中药片剂,主治胃癌,兼治咽喉癌、食管癌、喷门癌、大肠癌等消化系统癌症,本发明的特点是药味少,剂量适中,所选的药味大都是被现代医学药理实验证明是能够治疗癌症的。
Description
技术领域
本发明涉及的回族中药莪术胃癌康片是一种治疗晚期胃癌特别是因为各种原因无法进行手术的晚期胃癌的绿色高科技中草药。本发明还涉及该药的制备方法,属于中医药类。
背景技术
据《2014年中国肿瘤登记年报》数据显示,按照中国人平均74岁的寿命计算,中国人一生患恶性肿瘤的几率是22%,平均每分钟有6人被诊断为恶性肿瘤,肿瘤在中国已经成为一种常见疾病。目前中国的癌症患者约为700多万人,且每年以100多万人的速度在增加。而全世界呢?
据统计,在我国近800万的癌症患者中,有31.27%为消化系统癌患者,其中胃癌患者占消化系统癌患者的41.83%,几近一半。
中国是胃癌发病率最高的国家之一,全球每年新发胃癌患者100余万,中国就占了42%,死亡人数中国占到了35%,中国胃癌的发病率和死亡率均是世界平均水平的2倍多!这其中的遗传因素、免疫因素、幽门螺杆菌感染因素都不在话下,最让人揪心的则是环境和饮食因素……
胃癌的早期症状不明显,通常从胃癌发病到发现肿瘤需要两年左右的时间,因此往往被忽视,而一旦到了不可忍受,十有八九已到了晚期。
目前治胃癌最好的方法是手术,术后还要进行化疗,而化疗不但副作用大,患者痛苦难以忍受,而且成功率也很低,绝大多数患者化疗后的生存期连一年都不到——当然这也与无良医生的过度治疗有关。而另一方面,一些人虽然被检测出是胃癌,但是由于各种原因无法进行手术,只能姑息治疗,期待奇迹的降临……
胃癌是目前较难治愈的疾病,但难治并不代表没法可治,除上述西医治疗方法外,中医也有很多有效的治疗方法。中医以整体观念根据患者的全身特点辨证论治,可以适用于各型各期癌症。中医药治疗癌症的优势在于有利于稳定病情,毒副作用轻微、症状改善较明显,使病情发展减慢、肿瘤缩小或带瘤较长期生存,患者易于接受和费用比较低廉。目前西医也认为中医药可以作为癌症的辅助治疗,有助于减少放、化疗的毒性,改善癌症相关症状,提高生存质量,延长生存期。但存在的问题是中医的药方统一性较差,治疗主要凭的是经验。从已有的治癌验方、偏方看,所选中草药药材中总是有一些——多数是超过半数以上的——药物都是没有被现代医学药理实验证明是有治癌功能和作用的“辨证施治”的“配伍”药,本发明人认为挺不合适;而偏方呢,偏方治病靠的是试验,往往耽搁治病的时间。
发明内容
本发明的目的,就是针对中国癌症患者就诊难以及中医病方统一性差、可重复性差、高级别的循证医学理论和证据相对缺乏,因而治癌主要是凭经验等不足之情况,提出一种新的配药方法以及制备方法,提供一种从预防开始,降低胃癌的发病率,从癌变开始减缓其进展速度,从肿瘤开始诱导其萎缩凋亡的绿色高科技中草药。具体地说,本发明一是特别适用于治疗癌前较大胃溃疡以防其癌变,二是可治疗胃癌初期的特大胃溃疡,以防其继续恶化,三是可诱导已经成瘤的癌肿萎缩凋亡,以很低的花费,从根本上改善身体机能,从而恢复健康。它的最大优势在于能最大限度地诱导癌细胞自我凋亡与分化,促使癌肿逐步萎缩。在具体的配方中,还配合辨证施治,根据胃癌的成因因饮食因素使营养素失去平衡致免疫功能低下,因幽门螺旋杆菌感染引起胃部正常细胞被损害、凋亡,胃炎、消化道溃疡、淋巴增生性胃淋巴瘤“乘虚而入”邪毒压正,因病久瘀血内结邪毒夹裹瘀血乘虚流窜经络客于脏腑久而成积致胃癌转移等基本病理病机的特点,运用健脾益肾扶正祛邪攻补兼施之法,以纠正正气内虚、邪凝毒聚和脏腑阴阳失调功能降低之不足,调整并提高机体的免疫功能。同时根据患者的具体情况,分别采用不同的配方,或舒肝和胃、降逆止痛,或解毒祛瘀,清热养阴,或温中散寒,健脾和胃,或大补气血,健脾补肾……以达到攻补兼施、补泻并用、整体抑瘤的目的,从而提高胃癌治疗的整体疗效和远期疗效,为胃癌患者提供一种已经被现代医学药理实验证明是有治癌功能和作用的绿色高科技中草药配方以及配制方法,以很低或是较低的花费,从根本上改善身体机能,控制病情的恶化并使病情逐渐好转,最终恢复身体健康。由此也给患者一个根据个人病情、经济状况、个人意愿来综合考虑选择不同治疗方法或几种方法合用特别是中西医相结合综合治疗应用的余地,以期获得最佳疗效,轻松提高生存率——特别是5年以上生存率。
本发明所提出的技术方案是:
一、所述的治疗胃癌的回族中药莪术胃癌康片是由下列重量配比原料制成的:
莪术30g、 西洋参7g、 绞股蓝15g、 肿节风25g、
乌药5g、 凤尾草25g 半边莲20g、 半枝莲20g、
黄连3g、 山慈菇7g、 蜂 蜜50g 香菇20g、西红柿50g
此方为一日一剂煎服的基本方。在实际应用时,还可根据患者的体质及病症情况,增加1-3味中医“天人合一、辩证论治”理论的“辨证配伍”药。
考虑到用该基本方煎服汤药量大、味道欠佳,患者很难饮用,故必须应用特殊工艺进行制备。
二、将上述各原料制成本发明所述的中药片剂的制备方法为:
A、 提取物的制备
(1)、提取
a、第一次提取:将上述中草药的重量除西洋参、黄连、山慈菇、西红柿50g以外,全部放大10倍,清水清洗后,置于BT-2 不锈钢提取釜中,加7-9 倍自来水后,加热至100℃恒温提取1小时左右,分离提取液,加压过滤,滤液备用。
b、第二次提取:往提取釜内加入5-7 倍量的自来水,加热至100℃恒温提取半小时左右,分离提取液,加压过滤,滤液备用。
c、第三次提取:往提取釜内加入3-5倍量的自来水,加热至100℃恒温提取20分钟左右,分离提取液,加压过滤,滤液备用。
(2)、浓缩
将三次的提取液合并,置于B-500 型三效真空高能蒸发浓缩器内,减压( 负200mmHg),加热至80℃,浓缩至相对密度1.10 ~ 1.20,备用。
(3)、制粉
将西洋参7g、黄连3g、山慈菇7g放大10倍,一同粉碎为末,过80目筛,备用。
(4)、配料
在30 万级洁净车间内,将药粉与前述浓缩物以及蜂蜜50g一起置混合机中充分混合,搅拌均匀。
(5)、 烘干、粉碎
将混合均匀的药料置于烘箱中60-70℃烘烤4-5小时,然后粉碎,过100 目筛。
(6)、造粒
将混合均匀的药料置入造粒机中造粒。
(7)、整粒
将制好的颗粒进行整粒,过35目筛。
(8)、干燥
将整好的颗粒置入热循环干燥箱内,80℃下通风干燥至水分< 8%。
(9) 压片
将干燥混合所得药物加入硬脂酸镁混合均匀置于压片机中压片(亦可包衣),每片0.5g。
B、包装
将片剂装入玻璃瓶或聚乙烯塑料小瓶中,再将装好的小瓶装盒、装箱、灭菌( 采用60Co 辐照,辐照剂量为8kGy)。
C、 入库
将辐照过的成品按先进先出的原则进行入库。
本发明常规服用方法:上述片剂每日三次,每次15-18片,空腹( 服后半小时不可大量喝水,以免冲淡药液)。服药期间勿食用辛辣等对胃肠道刺激性较大的食物。本药三个月为一疗程,一般服用二至三个疗程,最多服用四个疗程。
本药以煎西红柿汤做药引子服用效果更佳。煎西红柿汤的具体做法是:取自然熟透的小西红柿(50克左右)切碎,锅内放10克左右植物油,加热,放入适量葱花、食盐,待葱花飘出香味时将切碎的西红柿倒入锅中煎炒1-2分钟,再沏入适量水滚开出锅即可。服药期间勿食用辛辣等对胃肠道刺激性较大的食物。
本发明各原料的作用:
莪术,性味功效: 味苦、辛,性温。行气破血,消积止痛。临床应用: 主要用于子宫颈癌,还适用于其他各种肿瘤如肝癌、胃癌、胰腺癌、卵巢癌、结肠癌、肺癌、皮肤癌、白血病、精原细胞癌、唇癌、外阴癌等。此外,本品还用于治疗症瘕积聚、脘腹胀痛、食积胀痛、经闭腹痛等。
西洋参,味甘、微苦,寒。归肺、心、肾、脾经。补气养阴,清火生津。主要成分为人参皂甙、挥发油、树脂等。西洋参是很好的补品,还是十大抗癌中药之一。西洋参分离现具有抗肿瘤作用的乙炔衍生物,比人参效果为佳。功效:益气生津,养阴清热。应用:肿瘤病人症见气阴两虚所致的心烦口渴、久咳干咳、痰少咯血、气短乏力、咽喉干燥、声音嘶哑、午后潮热、手足心热等,均可使用。
绞股蓝,绞股蓝系葫芦科草质藤本植物,性寒、味甘,有益气,安神,降血压之功效,民间称其为“神奇”的“不老长寿药草”。在中医学中,绞股蓝很多功效被应用于多个系统的相关疾病的治疗。在治疗肝癌,结肠癌,肺癌等多种恶性肿瘤上有一定的功效,但是需要计算好剂量。
肿节风,性味功效: 味辛,性平。清热解毒,祛风除湿,活血止痛。临床应用:适用于多种肿瘤,如食管癌、胃癌、结肠癌、直肠癌、胰腺癌、肝癌、急性白血病等。
乌药,性味功效: 叶辛,性温。温中散寒,理气止痛。临床应用: 近用于消化道肿瘤,如胃癌、肠癌,还用于膀胱癌等。此外,还用于治疗心胃气痛、吐泻腹痛、痛经、疝痛、尿频、风湿疼痛、跌打伤痛及外伤出血。
凤尾草,含黄酮类、甾醇、氨其酸、内酯、酚类及鞣质。药性苦、寒。归肝、胃、肺、大肠、膀胱经。药效败毒抗癌、清热除湿、凉血止血。药用:(1)败毒抗癌,用于癌瘤积毒:胃癌、直肠癌、肺癌等;(2)消热除湿,用于湿热炎症:急性肝炎等;(3)凉血止血,用于血热出血:血热尿血等。
半边莲 ,为桔梗科山梗菜属植物半边莲的全草。其味辛,微苦,性平。主要含半边莲碱(亦称山梗菜碱),其次还含有去氢半边莲碱(山梗菜酮碱)、氢化半边莲碱(山梗菜醇碱)等多种生物碱以及黄酮类、菊糖、琥珀酸钠、延胡索酸、对羟基苯甲酸钠和酚类等。还含有皂甙、氨基酸等。功能为清热解毒、利水消肿。主治毒蛇咬伤、疔疮疖肿、水肿、黄疸等病证。肝癌合并腹水、肺癌;此外,半边莲在治疗大肠癌、鼻咽癌、食道癌、胃癌、骨髓瘤、脑瘤等方面亦见报道。除抗肿瘤作用外,半边莲类生物碱有中枢兴奋作用,是重要的神经胆碱受体激动剂,它还有利尿、利胆、抑菌、抗炎、抗蛇毒等多种药理作用。
半枝莲,功效与作用是清热解毒,散瘀止血,利尿消肿,治热毒痈肿,咽喉疼痛,肺痈,肠痈,毒蛇咬伤,跌打损伤;吐血;衄血;血淋;肿;腹水及癌症。功效与作用及食用方法有半枝莲黄芪消症丸,四金化瘀排石汤,半枝莲补虚祛湿汤。
黄连,性味功效: 味苦、性寒。清热燥湿,泻火解毒。临床应用: 适用于多种胂瘤,如肝、胆肿瘤,舌癌,唇癌,食管癌,胃癌,膀胱癌等。此外,还适用于高热神昏、吐血、衄血、疔疮肿毒,湿疮瘙痒、急性结膜炎、口疮、细菌性痢疾、急性肠胄炎、热盛心烦、痞满、消渴、烧伤等症。
山慈茹,性味甘、辛、凉,小毒。归肝、肾、肺、胃、大肠经。药效:败毒抗癌、消肿散结。临床应用:适用于多种肿瘤,主要用于乳腺癌,亦用于恶性淋巴瘤、甲状腺癌、皮肤癌、宫颈癌、鼻咽癌、食管癌、白血病、胃癌等。此外,还适用于痈肿疔毒、淋巴结核、蛇咬伤及良性肿瘤,如甲状腺瘤、乳腺囊性增生、乳腺纤维瘤、血管瘤等。药用(1)败毒抗癌,用于癌瘤积毒。
蜂蜜,蜂蜜的功效与作用:1.心血管患者的佳品,蜂蜜能改善血液的成分,促进心脑和血管功能,因此经常服用于心血管病人很有好处;2.保护肝脏,蜂蜜对肝脏有保护作用,能促使肝细胞再生,对脂肪肝的形成有一定的抑制作用;3.增强抵抗力,食用蜂蜜能迅速补充体力,消除疲劳,增强对疾病的抵抗力;4.杀菌,蜂蜜还有杀菌的作用,经常食用蜜糖,不仅对牙齿无妨碍,还能在口腔内起到杀菌消毒的作用,蜂蜜能治疗中度的皮肤伤害,特别是烫伤,将蜂蜜当做皮肤伤口敷料时,细菌无法生长;5.促进睡眠,失眠的人在每天睡觉前口服1汤匙蜜糖(加入1杯温开水内),可以帮助尽快进入梦乡;6.促进胃肠蠕动,蜂蜜对胃肠功能有调节作用,可使胃酸分泌正常。动物实验证实,蜂蜜有增强肠蠕动的作用,可显著缩短排便时间。
香菇,性味甘,平,无毒。归肝;胃经。功能主治;扶正补虚;健脾开胃;祛风透疹;化痰理气;解毒;抗癌。主正气衰弱;神倦乏力;纳呆;消化不良;贫血;佝偻病;高血压;高脂血症;慢性肝炎;盗汗;小便不禁;水肿;麻疹透发不畅;荨麻疹;毒菇中毒;肿瘤;益气不饥,治风破血,益味助食,经常食用可以预防人体因缺乏维生素D引起的血磷和血钙代谢的障碍后所患的佝偻病,预防人体各种粘膜及皮肤的炎症,预防身体衰弱、毛细血管破裂,牙床以及腹腔出血等。药理作用:1.调节机体免疫,2. 抗肿瘤作用:香菇多糖双链核糖核酸有抗细胞增殖和抗癌作用,香菇多糖能促进抗体形成,活化巨噬细胞,降低甲基胆蒽诱发肿瘤的发生率。香菇多糖对强诱变剂伊磺酸甲酯直接阻止DNA复制有很强的抑制作用,从而具抗诱变活性。3.抗病毒作用:硫酸化香菇多糖可抑制艾滋病毒和人类T细胞白血病病毒I型。从香菇中提取的双链核糖核酸有抗病毒作用。4.抗肝炎作用:香菇多糖有抗慢性肝炎的作用,T细胞亚群功能低下及IL-2受体表达不足是慢性肝炎患者不能清除感染的重要原因。也有报道香菇多糖对人体淋巴细胞IL-2分泌及IL-2受体表达具有双向调节作用。5. 对血小板聚集的作用,6.抗氧化作用:香菇的水提取物对过氧化氢(H2O2)有清除作用。
西红柿,西红柿具有减肥瘦身、消除疲劳、增进食欲、提高对蛋白质的消化、减少胃胀食积等功效。近年来,在众多世界性组织推荐的防癌或保健食品中,西红柿总是位居前列。在大量的流行病调查和动物实验中发现,西红柿在防癌抗癌中的优异表现,主要源于其中的番茄红素。那么,番茄红素是如何防癌、抗癌的呢第一,通过一系列的生化作用,番茄红素能促进癌细胞分化(向良性方向转化),抑制癌细胞增殖。第二,可增强人体免疫功能。番茄红素能促进一些具有防癌、抗癌作用的细胞素分泌,如白细胞介素-ⅱ,激活淋巴细胞对癌细胞的溶解作用;被激活的淋巴细胞又能释放细胞素如肿瘤坏死因子等,对肿瘤细胞具有杀伤作用。第三,番茄红素具有较强的 抗氧化 作用。细胞的老化、损伤和癌变都和自由基作用有关,而抗氧化剂(如番茄红素等)在有效清除自由基,从而发挥全身保健作用,其中便包括在防癌作用中扮演重要角色。
本发明的效果:
主治:胃癌,特别是由于各种原因无法进行胃癌手术的晚期胃癌,以很低的花费,从根本上改善身体机能,控制肿瘤继续疯长并使其逐渐缩小最终消失,从而恢复身体健康。
兼治:咽喉癌、食管癌、喷门癌、幽门癌、大肠癌等消化系统癌症。
本方的特点在于:
1、药味多,剂量适中,不浪费。
2、所选的药味大都是被现代医学药理实验证明是能够治癌的,而已有的治癌验方,偏方中则总是有半数以上的药物都是没有被现代医学药理实验证明是有治癌功能和作用的。
3、针对病灶,箭箭穿心,即所选药味都特别特别钟情于射中靶心,药到病除。而不是只要治癌,就一哄而上,结果是“龙”多反而不好治水。
4、尽最大可能“中性化”,即所选药味总体上保持“中性”,不寒不燥,不热不凉。这样就能使患者在整个服药的周期内少吃苦头、少受煎熬。而真要是出现“上火”或者“下泄”的情况,则完全可以针对具体个体的具体情况,临时辩证地添加一点“止泄”、“降火”的药物具体解决。而不是一开始就想象着患者可能就会上吐或者下泻,而把一些不必要的药物添加进方子,使患者在很长很长的服药期间都一直服用,最终造成不良后果。
具体实施方式:将莪术30g、绞股蓝15g、肿节风25g、乌药5g、凤尾草25g、半边莲20g、半枝莲20g、蜂蜜50g、香菇20g各放大10倍,清水清洗后,置于BT-2 不锈钢提取釜中,加7-9倍自来水后,加热至100℃恒温提取1小时左右,分离提取液,加压过滤,滤液备用。第二次提取:往提取釜内加入5-7倍量的自来水,加热至100℃恒温提取半小时左右,分离提取液,加压过滤,滤液备用。第三次提取:往提取釜内加入3-5倍量的自来水,加热至100℃恒温提取20分钟左右,分离提取液,加压过滤,滤液备用。浓缩:将三次的提取液合并,置于B-500 型三效真空高能蒸发浓缩器内,减压( 负200mmHg),加热至80℃,浓缩至相对密度1.10 ~ 1.20,备用。制粉:将西洋参7g、黄连3g、山慈菇7g各放大10倍,一同粉碎为末,过80目筛,备用。配料:在30 万级洁净车间内,将药粉与前述浓缩物以及蜂蜜50g一起置混合机中充分混合,搅拌均匀。烘干、粉碎:将混合均匀的药料置于烘箱中60-70℃烘烤4-5小时,然后粉碎,过100 目筛。造粒:将混合均匀的药料置入造粒机中造粒。整粒:将制好的颗粒进行整粒,过35目筛。干燥:将整好的颗粒置入热循环干燥箱内,80℃下通风干燥至水分< 8%。压片:将干燥混合所得药物加入硬脂酸镁混合均匀置于压片机中压片(亦可包衣),每片0.5g。包装:将压好的片剂装入聚乙烯塑料小瓶中,再将装好的小瓶装盒、装箱、灭菌( 采用60Co 辐照,辐照剂量为8kGy)。最后,将辐照过的成品按先进先出的原则进行入库。
Claims (2)
1.回族中药“莪术胃癌康片”及其制备方法,其特征在于它是由下列重量配比的原料制成的:
莪术30g、 西洋参7g、 绞股蓝15g、
肿节风25g、
乌药5g、 凤尾草25g 半边莲20g、
半枝莲20g、
黄连3g、 山慈菇7g、 蜂 蜜50g 香菇20g、
西红柿50g
此方为一日一剂煎服的基本方,在实际应用时,还可根据患者的体质及病症情况,增加1-3味“辨证配伍”药。
2.根据权利要求1 所述的回族中药“莪术胃癌康片”的重量配比,其特征在于包括下述制备步骤:
A、 提取物的制备
(1)、提取
a、第一次提取:将上述中草药的重量除西洋参、黄连、山慈菇、西红柿50g以外,全部放大10倍,清水清洗后,置于BT-2 不锈钢提取釜中,加7-9 倍自来水后,加热至100℃恒温提取1小时左右,分离提取液,加压过滤,滤液备用;
b、第二次提取:往提取釜内加入5-7 倍量的自来水,加热至100℃恒温提取半小时左右,分离提取液,加压过滤,滤液备用;
c、第三次提取:往提取釜内加入3-5倍量的自来水,加热至100℃恒温提取20分钟左右,分离提取液,加压过滤,滤液备用;
(2)、浓缩
将三次的提取液合并,置于B-500 型三效真空高能蒸发浓缩器内,减压( 负200mmHg),加热至80℃,浓缩至相对密度1.10 ~ 1.20,备用;
(3)、制粉
将西洋参7g、黄连3g、山慈菇7g放大10倍,一同粉碎为末,过80目筛,备用;
(4)、配料
在30 万级洁净车间内,将药粉与前述浓缩物以及蜂蜜50g一起置混合机中充分混合,搅拌均匀;
(5)、 烘干、粉碎
将混合均匀的药料置于烘箱中60-70℃烘烤4-5小时,然后粉碎,过100 目筛;
(6)、造粒
将混合均匀的药料置入造粒机中造粒;
(7)、整粒
将制好的颗粒进行整粒,过35目筛;
(8)、干燥
将整好的颗粒置入热循环干燥箱内,80℃下通风干燥至水分< 8%;
(9) 压片
将干燥混合所得药物加入硬脂酸镁混合均匀置于压片机中压片(亦可包衣),每片0.5g;
B、包装
将片剂装入玻璃瓶或聚乙烯塑料小瓶中,再将装好的小瓶装盒、装箱、灭菌( 采用60Co 辐照,辐照剂量为8kGy);
C、 入库
将辐照过的成品按先进先出的原则进行入库。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510749396.4A CN106668722A (zh) | 2015-11-08 | 2015-11-08 | 回族中药莪术胃癌康片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510749396.4A CN106668722A (zh) | 2015-11-08 | 2015-11-08 | 回族中药莪术胃癌康片及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106668722A true CN106668722A (zh) | 2017-05-17 |
Family
ID=58858060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510749396.4A Withdrawn CN106668722A (zh) | 2015-11-08 | 2015-11-08 | 回族中药莪术胃癌康片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106668722A (zh) |
-
2015
- 2015-11-08 CN CN201510749396.4A patent/CN106668722A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106668722A (zh) | 回族中药莪术胃癌康片及其制备方法 | |
CN106668725A (zh) | 回族中药莪术胃癌康颗粒及其制备方法 | |
CN106668700A (zh) | 回族中药莪术胃癌康口服液及其制备方法 | |
CN106668717A (zh) | 回族中药莪术胃癌康丸及其制备方法 | |
CN106668580A (zh) | 回族中药莲蝎胃癌消丸及其制备方法 | |
CN106668533A (zh) | 回族中药慈菇胃癌消丸及其制备方法 | |
CN106668539A (zh) | 回族中药慈菇胃癌消颗粒及其制备方法 | |
CN106668732A (zh) | 回族中药花果胃癌消丸及其制备方法 | |
CN106668582A (zh) | 回族中药莲蝎胃癌消颗粒及其制备方法 | |
CN106668211A (zh) | 回族中药六根降癌片及其制备方法 | |
CN106668532A (zh) | 回族中药慈菇胃癌消口服液及其制备方法 | |
CN106668300A (zh) | 回族中药太子胃癌康丸及其制备方法 | |
CN106668311A (zh) | 回族中药太子胃癌康颗粒及其制备方法 | |
CN106668740A (zh) | 回族中药术子胃癌康片及其制备方法 | |
CN106668579A (zh) | 回族中药莲蝎胃癌消片及其制备方法 | |
CN106668218A (zh) | 回族中药太子胃癌康口服液及其制备方法 | |
CN106668522A (zh) | 回族中药慈菇胃癌消片及其制备方法 | |
CN106668416A (zh) | 回族中药三子胃癌康丸及其制备方法 | |
CN106668729A (zh) | 回族中药术子胃癌康丸及其制备方法 | |
CN106668724A (zh) | 回族中药术子胃癌康颗粒及其制备方法 | |
CN106668413A (zh) | 回族中药三子胃癌康片及其制备方法 | |
CN106668499A (zh) | 回族中药附札胃癌消片及其制备方法 | |
CN106668410A (zh) | 回族中药三子胃癌康颗粒及其制备方法 | |
CN106668213A (zh) | 回族中药六根降癌口服液及其制备方法 | |
CN106668215A (zh) | 回族中药六根降癌丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170517 |
|
WW01 | Invention patent application withdrawn after publication |